Download FREE Report Sample
Download Free sampleRecombinant DNA Technology Market contains market size and forecasts of Recombinant DNA (rDNA) Technology in Global, including the following market information:
Global Recombinant DNA (rDNA) Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Recombinant DNA (rDNA) Technology market was valued at 161950 million in 2021 and is projected to reach US$ 282780 million by 2028, at a CAGR of 8.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Expression System Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant DNA (rDNA) Technology include F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant DNA (rDNA) Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant DNA (rDNA) Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Recombinant DNA (rDNA) Technology Market Segment Percentages, by Type, 2021 (%)
Expression System
Cloning Vector
Global Recombinant DNA (rDNA) Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Recombinant DNA (rDNA) Technology Market Segment Percentages, by Application, 2021 (%)
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other
Global Recombinant DNA (rDNA) Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Recombinant DNA (rDNA) Technology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant DNA (rDNA) Technology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Recombinant DNA (rDNA) Technology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Profacgen
Amgen Inc
Novartis AG
GenScript
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Biocon
GlaxoSmithKline plc
New England Biolabs.
Cibus
Monsanto Company
Horizon Discovery Group PLC
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
